Case Study – Page 41

Unapproved process parameter change during commercial campaign – root cause analysis failure explained

Analyzing an Unapproved Change in Process Parameters During a Commercial Campaign During a recent commercial-scale pharmaceutical manufacturing campaign, a significant deviation was detected involving an unapproved change in process parameters.…

Unapproved process parameter change during tech transfer – regulatory impact assessment case study

Assessment of Unapproved Changes During Pharmaceutical Tech Transfer: A Case Study In the complex world of pharmaceutical manufacturing, deviations from established processes can lead to significant regulatory impacts and risks…

Deviation recurrence across batches during tech transfer – FDA inspection observation breakdown

Analyzing Deviations across Batches During Technology Transfer: A Case Study on FDA Observations Technology transfer in pharmaceutical manufacturing is a critical process that can introduce risks, including the potential for…

Unplanned hold time extension during inspection preparation – regulatory impact assessment case study

Case Study: Assessing the Regulatory Impact of Unplanned Hold Time Extensions During Inspection Preparation In pharmaceutical manufacturing, the unexpected occurrence of unplanned hold time during inspection preparation can significantly compromise…

Equipment used without release during routine manufacturing – FDA inspection observation breakdown

Breaking Down FDA Observations: Equipment Used Without Release in Manufacturing In pharmaceutical manufacturing, ensuring compliance with Good Manufacturing Practice (GMP) is critical to maintaining product quality and regulatory approval. This…

Equipment used without release during routine manufacturing – FDA inspection observation breakdown

Breakdown of FDA Inspection Findings on Unreleased Equipment Used in Manufacturing In a recent FDA inspection, a pharmaceutical manufacturing facility was cited for using equipment that had not undergone proper…

Process change implemented without QA approval during routine manufacturing – regulatory impact assessment case study

Case Study: Impact of Unapproved Process Change during Routine Manufacturing In a recent incident at a pharmaceutical manufacturing facility, a process change was implemented without the necessary Quality Assurance (QA)…

Process change implemented without QA approval during routine manufacturing – regulatory impact assessment case study

Assessment of a Manufacturing Process Change Implemented Without QA Approval In the highly regulated pharmaceutical industry, adherence to established protocols is paramount. This case study discusses a significant deviation where…

Deviation closed without effectiveness check during changeover – FDA inspection observation breakdown

Case Study: Addressing a Deviation Closed Without Effectiveness Check During Changeover Understanding and resolving manufacturing deviations is critical in pharmaceutical production. This case study focuses on a specific instance where…

Deviation closed without effectiveness check during changeover – FDA inspection observation breakdown

Case Study: Addressing a Deviation Closed Without Effectiveness Check During Changeover In the regulated environment of pharmaceutical manufacturing, adherence to Good Manufacturing Practices (GMP) is vital. However, deviations can occur,…

Batch executed with expired SOP during commercial campaign – root cause analysis failure explained

“`html Root Cause Analysis in Pharmaceutical Manufacturing: Addressing the Execution of a Batch with Expired SOP In a recent real-world scenario, a pharmaceutical manufacturer discovered that a batch of product…

Batch executed with expired SOP during commercial campaign – root cause analysis failure explained

Root Cause Analysis of a Batch Executed with Expired SOP During Commercial Campaign In the highly regulated pharmaceutical industry, adherence to Standard Operating Procedures (SOPs) is critical for ensuring product…